Feasibility, acceptance and effects of pulsed magnetic field therapy in patients with post-COVID-19 fatigue syndrome DOI Creative Commons

Mohammad Kéilani,

M. Steiner, Julia Sternik

и другие.

Wiener klinische Wochenschrift, Год журнала: 2025, Номер unknown

Опубликована: Март 17, 2025

Summary Introduction The aim of this randomized, single-blinded, placebo-controlled pilot study was to explore the feasibility, acceptance and effects pulsed electromagnetic field therapy (PEMF) in patients with post-COVID-19 fatigue syndrome. Methods A total 20 were included study. They randomly assigned an intervention group ( n = 10, male:female 4 : 5, age 45 ± 9 years) a placebo m:f 4:6, age: 39 23 years). Papimi™ Delta professional device used for treatment. Controls received PEMF. In 10 PEMF sessions (30 min., 2× per week) applied. Physical performance, health-related quality life, fatigue, work ability, sleep, pain, anxiety depression assessed at baseline, posttreatment follow-up 5 weeks after Feasibility posttreatment. Results showed notable improvement 6 minutes walking test. use improved (measured Brief Fatigue Inventory Multidimensional Inventory). Also, subscale Hospital Anxiety Depression Scale, Insomnia Severity Index, Work Ability Index most subscales Short Form (SF) 36 questionnaire improvement. From three dropped out. There no drop-outs group. group, well-accepted very good adherence. Conclusion results indicate that is feasible well accepted. Furthermore, population improvements physical mental health This promising contribution growing research provides required evidence future efficacy studies on patients.

Язык: Английский

Feasibility, acceptance and effects of pulsed magnetic field therapy in patients with post-COVID-19 fatigue syndrome DOI Creative Commons

Mohammad Kéilani,

M. Steiner, Julia Sternik

и другие.

Wiener klinische Wochenschrift, Год журнала: 2025, Номер unknown

Опубликована: Март 17, 2025

Summary Introduction The aim of this randomized, single-blinded, placebo-controlled pilot study was to explore the feasibility, acceptance and effects pulsed electromagnetic field therapy (PEMF) in patients with post-COVID-19 fatigue syndrome. Methods A total 20 were included study. They randomly assigned an intervention group ( n = 10, male:female 4 : 5, age 45 ± 9 years) a placebo m:f 4:6, age: 39 23 years). Papimi™ Delta professional device used for treatment. Controls received PEMF. In 10 PEMF sessions (30 min., 2× per week) applied. Physical performance, health-related quality life, fatigue, work ability, sleep, pain, anxiety depression assessed at baseline, posttreatment follow-up 5 weeks after Feasibility posttreatment. Results showed notable improvement 6 minutes walking test. use improved (measured Brief Fatigue Inventory Multidimensional Inventory). Also, subscale Hospital Anxiety Depression Scale, Insomnia Severity Index, Work Ability Index most subscales Short Form (SF) 36 questionnaire improvement. From three dropped out. There no drop-outs group. group, well-accepted very good adherence. Conclusion results indicate that is feasible well accepted. Furthermore, population improvements physical mental health This promising contribution growing research provides required evidence future efficacy studies on patients.

Язык: Английский

Процитировано

0